Cargando…
A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity
SIMPLE SUMMARY: Cancer remains a major health issue, and the development of new drug strategy is still mandatory. Currently, rodent models remain widely used in order to identify the first proof of concept of drug efficacy. Nevertheless, ethical considerations, cost, and time constraints highlight t...
Autores principales: | Rupp, Tristan, Legrand, Christophe, Hunault, Marion, Genest, Laurie, Babin, David, Froget, Guillaume, Castagné, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325108/ https://www.ncbi.nlm.nih.gov/pubmed/35884608 http://dx.doi.org/10.3390/cancers14143548 |
Ejemplares similares
-
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response
por: Rupp, Tristan, et al.
Publicado: (2022) -
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models
por: Rupp, Tristan, et al.
Publicado: (2020) -
Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models
por: Davy, Mélodie, et al.
Publicado: (2023) -
Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models
por: Rupp, Tristan, et al.
Publicado: (2022) -
Extending the Applicability of In Ovo and Ex Ovo Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells
por: Merlos Rodrigo, Miguel Angel, et al.
Publicado: (2021)